MAIA Biotechnology

Maia Biotechnology

Biotechnology, 444 W Lk St, Chicago, Illinois, 60606, United States, 1-10 Employees

maiabiotech.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 31********

Who is MAIA BIOTECHNOLOGY

MAIA Biotechnology is a targeted therapy, immune-oncology company, focused on development and commercialization of first-in-class drugs with novel mechanisms of action that are intended t...

Read More

map

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from MAIA BIOTECHNOLOGY

MAIA Biotechnology Org Chart and Mapping

Vlad Vitoc

President & Chief Executive Officer

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding MAIA Biotechnology

Answer: MAIA Biotechnology's headquarters are located at 444 W Lk St, Chicago, Illinois, 60606, United States

Answer: MAIA Biotechnology's phone number is 31********

Answer: MAIA Biotechnology's official website is https://maiabiotech.com

Answer: MAIA Biotechnology's revenue is $1 Million to $5 Million

Answer: MAIA Biotechnology's SIC: 2836

Answer: MAIA Biotechnology's NAICS: 541714

Answer: MAIA Biotechnology has 1-10 employees

Answer: MAIA Biotechnology is in Biotechnology

Answer: MAIA Biotechnology contact info: Phone number: 31******** Website: https://maiabiotech.com

Answer: MAIA Biotechnology is a targeted therapy, immune-oncology company, focused on development and commercialization of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. A publicly traded company based in Chicago, MAIA (NYSE American: MAIA) is led by a passionate, principled and highly experienced Management Team with significant drug development experience, committed to advancing promising agents into human clinical trials. MAIAs business strategy is designed to advance a strong value proposition for its portfolio of potentially novel compounds. MAIA controls risk and enhances its opportunity for success by diversifying and generating this portfolio of assets with a variety of compounds with novel mechanisms of action which have potential activity in multiple tumor types. MAIAs business model involves placing drug candidates in their own dedicated, R&D focused subsidiary company, which is supported by the common infrastructure, management team, and resources of the MAIA enterprise. This model allows MAIA to provide more focused R&D support to each drug candidate, while also distributing shared central resources among subsidiary companies to maintain a lean, capital-efficient operating structure.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access